KHDRBS1 Antibody - #DF7853
Product: | KHDRBS1 Antibody |
Catalog: | DF7853 |
Description: | Rabbit polyclonal antibody to KHDRBS1 |
Application: | WB IHC |
Reactivity: | Human, Mouse |
Prediction: | Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken |
Mol.Wt.: | 48 kDa; 48kD(Calculated). |
Uniprot: | Q07666 |
RRID: | AB_2841288 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF7853, RRID:AB_2841288.
Fold/Unfold
FLJ34027; GAP associated tyrosine phosphoprotein p62; GAP-associated tyrosine phosphoprotein p62; KH domain containing RNA binding signal transduction associated 1; KH domain-containing; KHDR1_HUMAN; Khdrbs1; p21 Ras GTPase activating protein associated p62; p21 Ras GTPase-activating protein-associated p62; p62; p68; RNA-binding; Sam68; signal transduction-associated protein 1; Src associated in mitosis 68 kDa protein; Src-associated in mitosis 68 kDa protein;
Immunogens
Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver.
- Q07666 KHDR1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MQRRDDPAARMSRSSGRSGSMDPSGAHPSVRQTPSRQPPLPHRSRGGGGGSRGGARASPATQPPPLLPPSATGPDATVGGPAPTPLLPPSATASVKMEPENKYLPELMAEKDSLDPSFTHAMQLLTAEIEKIQKGDSKKDDEENYLDLFSHKNMKLKERVLIPVKQYPKFNFVGKILGPQGNTIKRLQEETGAKISVLGKGSMRDKAKEEELRKGGDPKYAHLNMDLHVFIEVFGPPCEAYALMAHAMEEVKKFLVPDMMDDICQEQFLELSYLNGVPEPSRGRGVPVRGRGAAPPPPPVPRGRGVGPPRGALVRGTPVRGAITRGATVTRGVPPPPTVRGAPAPRARTAGIQRIPLPPPPAPETYEEYGYDDTYAEQSYEGYEGYYSQSQGDSEYYDYGHGEVQDSYEAYGQDDWNGTRPSLKAPPARPVKGAYREHPYGRY
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q07666 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
R10 | Methylation | Uniprot | |
S12 | Phosphorylation | Uniprot | |
S14 | Phosphorylation | Uniprot | |
S15 | Phosphorylation | Uniprot | |
R17 | Methylation | Uniprot | |
S18 | Phosphorylation | Uniprot | |
S20 | Phosphorylation | Uniprot | |
S24 | Phosphorylation | Uniprot | |
S29 | Phosphorylation | Uniprot | |
T33 | Phosphorylation | Uniprot | |
S35 | Phosphorylation | Uniprot | |
R36 | Methylation | Uniprot | |
R43 | Methylation | Uniprot | |
S44 | Phosphorylation | Uniprot | |
R45 | Methylation | Uniprot | |
R52 | Methylation | Uniprot | |
S58 | Phosphorylation | P28482 (MAPK1) , Q16539 (MAPK14) | Uniprot |
T61 | Phosphorylation | Uniprot | |
T72 | Phosphorylation | P28482 (MAPK1) | Uniprot |
T77 | Phosphorylation | Uniprot | |
T84 | Phosphorylation | P28482 (MAPK1) , Q16539 (MAPK14) | Uniprot |
K96 | Acetylation | Uniprot | |
K96 | Sumoylation | Uniprot | |
K102 | Sumoylation | Uniprot | |
Y103 | Phosphorylation | Uniprot | |
K111 | Ubiquitination | Uniprot | |
S113 | Phosphorylation | Uniprot | |
T119 | Phosphorylation | Uniprot | |
K131 | Ubiquitination | Uniprot | |
S137 | Phosphorylation | Uniprot | |
K139 | Ubiquitination | Uniprot | |
Y145 | Phosphorylation | Uniprot | |
S150 | Phosphorylation | Uniprot | |
K152 | Ubiquitination | Uniprot | |
K165 | Acetylation | Uniprot | |
K165 | Ubiquitination | Uniprot | |
K169 | Acetylation | Uniprot | |
K169 | Ubiquitination | Uniprot | |
K175 | Acetylation | Uniprot | |
K175 | Methylation | Uniprot | |
K175 | Sumoylation | Uniprot | |
K175 | Ubiquitination | Uniprot | |
T183 | Phosphorylation | Uniprot | |
K185 | Sumoylation | Uniprot | |
K185 | Ubiquitination | Uniprot | |
K194 | Methylation | Uniprot | |
K194 | Ubiquitination | Uniprot | |
S196 | Phosphorylation | Uniprot | |
K200 | Methylation | Uniprot | |
K200 | Ubiquitination | Uniprot | |
S202 | Phosphorylation | Uniprot | |
K208 | Acetylation | Uniprot | |
R213 | Methylation | Uniprot | |
K252 | Acetylation | Uniprot | |
K253 | Acetylation | Uniprot | |
R282 | Methylation | Uniprot | |
R284 | Methylation | Uniprot | |
R289 | Methylation | Uniprot | |
R291 | Methylation | Uniprot | |
R302 | Methylation | Uniprot | |
R304 | Methylation | Uniprot | |
R310 | Methylation | Uniprot | |
R315 | Methylation | Uniprot | |
T317 | Phosphorylation | P06493 (CDK1) | Uniprot |
R320 | Methylation | Uniprot | |
R325 | Methylation | Uniprot | |
R331 | Methylation | Uniprot | |
R340 | Methylation | Uniprot | |
R346 | Methylation | Uniprot | |
R348 | Methylation | Uniprot | |
T365 | Phosphorylation | Uniprot | |
Y366 | Phosphorylation | Uniprot | |
Y369 | Phosphorylation | Uniprot | |
Y371 | Phosphorylation | Uniprot | |
T374 | Phosphorylation | Uniprot | |
Y375 | Phosphorylation | Uniprot | |
Y380 | Phosphorylation | Uniprot | |
Y387 | Phosphorylation | Uniprot | |
S388 | Phosphorylation | Uniprot | |
S390 | Phosphorylation | Uniprot | |
Y396 | Phosphorylation | Uniprot | |
Y397 | Phosphorylation | Uniprot | |
Y408 | Phosphorylation | Uniprot | |
Y411 | Phosphorylation | Uniprot | |
K424 | Ubiquitination | Uniprot | |
K432 | Methylation | Uniprot | |
K432 | Ubiquitination | Uniprot | |
Y435 | Phosphorylation | Q13882 (PTK6) | Uniprot |
Y440 | Phosphorylation | Q13882 (PTK6) | Uniprot |
R442 | Methylation | Uniprot | |
Y443 | Phosphorylation | Q13882 (PTK6) | Uniprot |
Research Backgrounds
Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. According to some authors, is not involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species according to. RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). Can regulate CD44 alternative splicing in a Ras pathway-dependent manner (By similarity). In cooperation with HNRNPA1 modulates alternative splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and of SMN1. Can regulate alternative splicing of NRXN1 and NRXN3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. In a neuronal activity-dependent manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is antagonistic for regulation of NXRN3 alternative splicing at AS4 (By similarity).
Isoform 3, which is expressed in growth-arrested cells only, inhibits S phase.
Tyrosine phosphorylated by several non-receptor tyrosine kinases including LCK, FYN and JAK3. Also tyrosine phosphorylated by the non-receptor tyrosine kinase SRMS in an EGF-dependent manner. Negatively correlates with ability to bind RNA but required for many interactions with proteins. Phosphorylation by PTK6 negatively regulates its RNA binding ability. Phosphorylation by PTK6 at Tyr-440 dictates the nuclear localization of KHDRBS1. Phosphorylation at Tyr-387 disrupts interaction with APC. Phosphorylation at tyrosine residues by FYN inverts activity on modulation of BCL2L1 alternative splicing.
Acetylated. Positively correlates with ability to bind RNA.
Arginine methylation is required for nuclear localization. Also can affect interaction with other proteins. Inhibits interaction with Src-like SH3 domains, but not interaction with WW domains of WBP4/FBP21 AND FNBP4/FBP30.
Nucleus. Cytoplasm. Membrane.
Note: Predominantly located in the nucleus but also located partially in the cytoplasm.
Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver.
Self-associates to form homooligomers when bound to RNA, oligomerization appears to be limited when binding to proteins; dimerization increases RNA affinity. Interacts with KHDRBS3/SLIM-2. Interacts with KHDRBS2/SLIM-1; heterooligomer formation of KHDRBS family proteins may modulate RNA substrate specificity (By similarity). Interacts with RASA1, LCK, FYN, PTPN6, PLCG1, GRB2, CBL, JAK3, PIK3R, STAT3, APC, HNRNPA1. Interacts with PTK6 (via SH3 and SH2 domains). Forms a complex with ILF2, ILF3, YLPM1, RBMX, NCOA5 and PPP1CA. Does not interact with TPR. Interacts with RBMY1A1, PRMT1 (By similarity). Binds WBP4/FBP21 (via WW domains), FNBP4/FBP30 (via WW domains). Interacts (via Arg/Gly-rich-flanked Pro-rich regions) with FYN (via the SH3 domain) (By similarity). Interacts with the non-receptor tyrosine kinase SRMS; the interaction leads to phosphorylation of KHDRBS1. Interacts with ZBTB7A; negatively regulates KHDRBS1 splicing activity toward BCL2L1.
The KH domain is required for binding to RNA.
The Pro-rich domains are flanked by Arg/Gly-rich motifs which can be asymmetric dimethylated on arginine residues to give the DMA/Gly-rich regions. Selective methylation on these motifs can modulate protein-protein interactions (By similarity).
Belongs to the KHDRBS family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.